Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,116.00GBp
8 Dec 2016
Change (% chg)

109.00p (+2.72%)
Prev Close
4,007.00p
Open
4,028.50p
Day's High
4,117.00p
Day's Low
4,011.00p
Volume
3,867,870
Avg. Vol
2,848,784
52-wk High
5,505.00p
52-wk Low
3,680.00p

Berger, Genevieve 

Ms. Genevieve Berger is Non-Executive Independent Director of AstraZeneca Plc., effective April 26, 2012. She was Chief Science Officer at Unilever PLC and a member of the Unilever Leadership Executive from 2008 to April 2014. She holds three doctorates – in physics, human biology and medicine – and was appointed Professor of Medicine at Université Pierre et Marie Curie, Paris in 2006. Her previous positions include Professor and Hospital Practitioner at l’Hôpital de la Pitié-Salpêtrière, Paris; Director of the Biotech and Agri-Food Department, then Head of the Technology Directorate at the French Ministry of Research and Technology; Director General, Centre National de la Recherche Scientifique; and Chairman of the Health Advisory Board of the EU Commission.

Basic Compensation

Total Annual Compensation, GBP 87,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 87,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

609,000

Pascal Soriot

8,397,000

Marc Dunoyer

5,955,000

Fiona Cicconi

--

Sean Bohen

--

Pam Cheng

--
As Of  30 Dec 2015